Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina M Ronen

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|November 6, 2003
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer modelsYuen-Li Chung, Helen Troy, Udai Banerji, et al.
Nature Communications|September 11, 2013
Non-invasive in vivo assessment of IDH1 mutational status in gliomaMyriam M Chaumeil, Peder E Z Larson, Hikari A I Yoshihara, et al.
Magnetic Resonance in Medicine|August 2, 2012
Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imagingIlwoo Park, Simon Hu, Robert Bok, et al.
Cancer Research|September 22, 2020
Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide TreatmentElavarasan Subramani, Marina Radoul, Chloe Najac, et al.
Neuro-Oncology|December 25, 2013
Lactate dehydrogenase A silencing in IDH mutant gliomasCharles Chesnelong, Myriam M Chaumeil, Michael D Blough, et al.
Molecular Imaging|August 19, 2008
Monitoring histone deacetylase inhibition in vivo: noninvasive magnetic resonance spectroscopy methodMadhuri Sankaranarayanapillai, William P Tong, Qing Yuan, et al.
Neuro-Oncology|April 23, 2022
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastomaNoriaki Minami, Donghyun Hong, Nicholas Stevers, et al.
Neuro-Oncology Advances|September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant gliomaLindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
Cancer Research|June 6, 2015
IDH1 Mutation Induces Reprogramming of Pyruvate MetabolismJose L Izquierdo-Garcia, Pavithra Viswanath, Pia Eriksson, et al.
Scientific Reports|March 23, 2017
Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating GliomaLlewellyn E Jalbert, Adam Elkhaled, Joanna J Phillips, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|November 6, 2003
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer modelsYuen-Li Chung, Helen Troy, Udai Banerji, et al.
Nature Communications|September 11, 2013
Non-invasive in vivo assessment of IDH1 mutational status in gliomaMyriam M Chaumeil, Peder E Z Larson, Hikari A I Yoshihara, et al.
Magnetic Resonance in Medicine|August 2, 2012
Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imagingIlwoo Park, Simon Hu, Robert Bok, et al.
Cancer Research|September 22, 2020
Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide TreatmentElavarasan Subramani, Marina Radoul, Chloe Najac, et al.
Neuro-Oncology|December 25, 2013
Lactate dehydrogenase A silencing in IDH mutant gliomasCharles Chesnelong, Myriam M Chaumeil, Michael D Blough, et al.
Molecular Imaging|August 19, 2008
Monitoring histone deacetylase inhibition in vivo: noninvasive magnetic resonance spectroscopy methodMadhuri Sankaranarayanapillai, William P Tong, Qing Yuan, et al.
Neuro-Oncology|April 23, 2022
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastomaNoriaki Minami, Donghyun Hong, Nicholas Stevers, et al.
Neuro-Oncology Advances|September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant gliomaLindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
Cancer Research|June 6, 2015
IDH1 Mutation Induces Reprogramming of Pyruvate MetabolismJose L Izquierdo-Garcia, Pavithra Viswanath, Pia Eriksson, et al.
Scientific Reports|March 23, 2017
Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating GliomaLlewellyn E Jalbert, Adam Elkhaled, Joanna J Phillips, et al.
Pageof 8